Research output per year
Research output per year
Fingerprint
Dive into the research topics where Padraig E O'Suilleabhain is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of ETStig, a measure for stigma in essential tremor
O'Suilleabhain, P., Tovar, M., Shukla, A. W., Tester, N. J., Lundervold, D. A., Turner, T. H., Howe-Martin, L. & Louis, E. D., Nov 2022, In: Parkinsonism and Related Disorders. 104, p. 38-43 6 p.Research output: Contribution to journal › Article › peer-review
-
Yet Another Way to Lower Homocysteine: Close the Patent Foramen Ovale
O'Suilleabhain, P., Jul 13 2021, In: Neurology. 97, 2, p. 55-56 2 p.Research output: Contribution to journal › Editorial › peer-review
-
Safety and tolerability of srx246, a vasopressin 1a antagonist, in irritable huntington’s disease patients—a randomized phase 2 clinical trial
Brownstein, M. J., Simon, N. G., Long, J. D., Yankey, J., Maibach, H. T., Cudkowicz, M., Coffey, C., Conwit, R. A., Lungu, C., Anderson, K. E., Hersch, S. M., Ecklund, D. J., Damiano, E. M., Itzkowitz, D. E., Lu, S., Chase, M. K., Shefner, J. M., McGarry, A., Thornell, B., Gladden, C., & 46 others, Nov 2020, In: Journal of Clinical Medicine. 9, 11, p. 1-14 14 p., 3682.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
Boxer, A. L., Qureshi, I., Ahlijanian, M., Grundman, M., Golbe, L. I., Litvan, I., Honig, L. S., Tuite, P., McFarland, N. R., O'Suilleabhain, P., Xie, T., Tirucherai, G. S., Bechtold, C., Bordelon, Y., Geldmacher, D. S., Grossman, M., Isaacson, S., Zesiewicz, T., Olsson, T., Muralidharan, K. K., & 4 others, Jun 2019, In: The Lancet Neurology. 18, 6, p. 549-558 10 p.Research output: Contribution to journal › Article › peer-review
83 Scopus citations -
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
McGarry, A., McDermott, M., Kieburtz, K., DeBlieck, E. A., Beal, F., Marder, K., Ross, C., Shoulson, I., Gilbert, P., Mallonee, W. M., Guttman, M., Wojcieszek, J., Kumar, R., LeDoux, M. S., Jenkins, M., Rosas, H. D., Nance, M., Biglan, K., Como, P., Dubinsky, R. M., & 40 others, Jan 10 2017, In: Neurology. 88, 2, p. 152-159 8 p.Research output: Contribution to journal › Article › peer-review
89 Scopus citations